https://www.pharmatell.com/eyes-on-pharma-blogRSS for NodeThu, 10 Sep 2026 21:01:45 GMThttps://www.pharmatell.com/eyes-on-pharma/eyeson-biopharma-news6a99c4919a8c0053173bb79bThu, 10 Sep 2026 14:00:15 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/eyeson-clinical-assets6a91bb19e2003eee181cf670Fri, 04 Sep 2026 14:30:03 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/corporate-strategy-updates-biontech-pfizer-and-astra-zeneca-bms6a872c6e0c902f24d9c2300bFri, 28 Aug 2026 13:30:06 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/recent-clinical-updates-otsuka-sanofi6a872c181ba312f5c1a32e6dSat, 22 Aug 2026 16:32:54 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/eyeson-industry-news-sanofi-merck-kgaa6a5b98e8830cbda37bbee72fFri, 07 Aug 2026 13:30:07 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/eyeson-orca-vertex-ipsen-clinical-data6a5b988ef41b637093b1872eFri, 31 Jul 2026 13:30:09 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/eyeson-the-competitive-edge6a59213848b343e14f139fa6Fri, 24 Jul 2026 14:30:06 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/eyeson-abbvie-sangamo-and-pfizer6a591bb6cb28250fe83b4aaeFri, 17 Jul 2026 14:30:10 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/eyeson-risk-management-in-action6a4439ea3c06bdad542a5e9bMon, 06 Jul 2026 14:30:18 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/eyeson-oncology-clinical-data6a4429ca3c06bdad542a3cd1Wed, 01 Jul 2026 14:00:29 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/eyeson-strategic-agility6a21d87a14f1bdc719628df0Sun, 21 Jun 2026 22:00:18 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/pharma-phriday-on-sabbatical-until-fall6a355def217d21f7fb62f23cFri, 19 Jun 2026 15:24:10 GMTRobin Batemanhttps://www.pharmatell.com/eyes-on-pharma/eyeson-optimizing-bd-strategy6a21d23caaa8d363bc43c03aMon, 15 Jun 2026 14:30:10 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/pharma-phriday-june-12-20266a2acda7948ac681a4fda139Fri, 12 Jun 2026 06:45:05 GMTDuncan Emertonhttps://www.pharmatell.com/eyes-on-pharma/pharma-phriday-june-5-20266a213b0614173fc57222277fFri, 05 Jun 2026 06:45:04 GMTDuncan Emertonhttps://www.pharmatell.com/eyes-on-pharma/4-eyeson-leveraging-clinical-results69f3b5abc99eb1cb510bd08aSun, 31 May 2026 16:46:05 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/pharma-phriday-may-29-20266a1814edf840e8662c455118Fri, 29 May 2026 06:45:06 GMTDuncan Emertonhttps://www.pharmatell.com/eyes-on-pharma/pharma-phriday-may-22-20266a0eceecd6452a126c2eedeaFri, 22 May 2026 06:45:06 GMTDuncan Emertonhttps://www.pharmatell.com/eyes-on-pharma/3-eyeson-strategic-growth-via-m-a69f3b4871f713e5a3388e924Tue, 19 May 2026 22:18:28 GMTJana Chisholmhttps://www.pharmatell.com/eyes-on-pharma/pharma-phriday-may-15-20266a05ed169f0dce7b598fe10dFri, 15 May 2026 12:00:13 GMTDuncan Emerton